Forma inks tech deal with Cubist

Forma Therapeutics has inked a deal to use its technology to help Cubist Pharmaceuticals discover antibacterial therapies. The deal calls for $14 million over the next three years and up to $54 million in milestones. Forma got started with the help of a group of top scientists from the Broad Institute of Harvard and MIT. Release l Report